Revoi.in

Business

Torrent Pharma announces Q2 FY25 results

October 25, 2024 revoi editor

Torrent Pharma announces Q2 FY25 results. Revenue at Rs. 2,889 crores grew by 9%, Gross Margin: 76.5%, Op. EBITDA margin at 32.5%. Op. EBITDA at Rs.939 crores, up by 14%. Net Profit after tax at Rs. 453 crores, up by 17%, Insulin revenues were impacted this quarter due to scheduled shutdown taken in the month […]

Business

Torrent Pharma announces Q1 FY25 results

July 23, 2024 Vinayak Barot

Revenue & profitability: Revenue at Rs. 2,859 crores grew by 10% Gross Margin: 75.7%, Op. EBITDA margin at 31.6%, Growth: 14% Net Profit after tax at Rs. 457 crores, up by 21% Other expenses include one-off expenses of Rs. 20 crores (in international business) Adjusted for such one-off expenses, the underlying Op. EBITDA is Rs. […]

Business

Torrent Pharma Q4 Results, Net profit jumps 57%

May 24, 2024 Vinayak Barot

Drug firm Torrent Pharmaceuticals Ltd on Friday (May 24) reported a 56.5% year-on-year (YoY) jump in net profit at ₹449 crore for the fourth quarter that ended March 31, 2024. In the corresponding quarter, Torrent Pharmaceuticals posted a net profit of ₹287 crore, the company said in a regulatory filing. The company’s revenue from operations […]

Business

Torrent Pharma announces Q2 FY24 results, Branded markets continue to deliver strong growth

October 23, 2023 Vinayak Barot

Ahmedabad, October 23, 2023: India: India revenue at Rs 1,444 crores grew by 18% As per AIOCD secondary market data, IPM growth for the quarter was 4%. ∙ Market outperformance was led by continued double digit growth in chronic therapies, revival in gastro demand, traction in consumer division, and new launches. ∙ Curatio portfolio grew […]

Business

Torrent Pharma announces Q1 FY24 results, Revenue at Rs. 2,591 crores up by 10%

August 9, 2023 Vinayak Barot

Revenue & profitability: Revenue at Rs. 2,591 crores up by 10%. Gross margin: 74.9%; Op. EBITDA: 30.5% Op. EBITDA at Rs. 791 crores up by 11%. Adjusted for one off income in both periods, it is up by 16%. Profit after tax at Rs. 378 crores Performance summary: Results Q1 FY24 Q1 FY23 YoY% Rs […]

Business

Torrent Pharma announces Q1 FY24 results

August 7, 2023 Vinayak Barot

Revenue & profitability: ∙ Revenue at Rs. 2,591 crores up by 10%. ∙ Gross margin: 74.9%; Op. EBITDA: 30.5% ∙ Op. EBITDA at Rs. 791 crores up by 11%. Adjusted for one off income in both periods, it is up by 16%. ∙ Profit after tax at Rs. 378 crores Performance summary: Results Q1 FY24 […]